Loading...

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

This case report describes how eculizumab reversed neurologic impairment and improved renal damage in severe atypical hemolytic uremic syndrome. A 50-year-old female, after presenting with diarrhea and abdominal pain, developed pancolitis, acute renal failure, and thrombocytopenia. The patient under...

Full description

Saved in:
Bibliographic Details
Main Authors: Ohanian, Maro, Cable, Christian, Halka, Kathleen
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2011
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3262387/
https://ncbi.nlm.nih.gov/pubmed/22287852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S17904
Tags: Add Tag
No Tags, Be the first to tag this record!